322 related articles for article (PubMed ID: 17537489)
1. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
3. What is the clinical value of cancer stem cell markers in gliomas?
Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
[TBL] [Abstract][Full Text] [Related]
4. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Musashi-1 in gliomas.
Dahlrot RH; Hansen S; Herrstedt J; Schrøder HD; Hjelmborg J; Kristensen BW
J Neurooncol; 2013 Dec; 115(3):453-61. PubMed ID: 24057325
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin L in glioma progression: comparison with cathepsin B.
Strojnik T; Kavalar R; Trinkaus M; Lah TT
Cancer Detect Prev; 2005; 29(5):448-55. PubMed ID: 16183211
[TBL] [Abstract][Full Text] [Related]
7. The pathological characteristics of glioma stem cell niches.
He H; Li MW; Niu CS
J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
[TBL] [Abstract][Full Text] [Related]
8. Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas.
Ishiwata T; Teduka K; Yamamoto T; Kawahara K; Matsuda Y; Naito Z
Oncol Rep; 2011 Jul; 26(1):91-9. PubMed ID: 21503585
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
10. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
11. Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas.
Arai H; Ikota H; Sugawara K; Nobusawa S; Hirato J; Nakazato Y
Brain Tumor Pathol; 2012 Jul; 29(3):160-7. PubMed ID: 22350668
[TBL] [Abstract][Full Text] [Related]
12. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
Li MW; Niu CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
[TBL] [Abstract][Full Text] [Related]
13. Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.
Sakakibara S; Imai T; Hamaguchi K; Okabe M; Aruga J; Nakajima K; Yasutomi D; Nagata T; Kurihara Y; Uesugi S; Miyata T; Ogawa M; Mikoshiba K; Okano H
Dev Biol; 1996 Jun; 176(2):230-42. PubMed ID: 8660864
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neural stem cell markers, Nestin and Musashi-1, in oral squamous cell carcinoma: expression pattern of Nestin in the precancerous stages of oral squamous epithelium.
Ravindran G; Devaraj H
Clin Oral Investig; 2015 Jul; 19(6):1251-60. PubMed ID: 25352468
[TBL] [Abstract][Full Text] [Related]
15. Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.
Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Fragkou P; Boviatsis E; Themistocleous MS; Petraki K; Vrettakos G; Sakalidou M; Samaras V; Zisakis A; Saetta A; Chatziandreou I; Patsouris E; Piperi C
Br J Cancer; 2013 May; 108(10):2142-52. PubMed ID: 23619925
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue.
Tomita T; Akimoto J; Haraoka J; Kudo M
Brain Tumor Pathol; 2014 Jul; 31(3):162-71. PubMed ID: 24202294
[TBL] [Abstract][Full Text] [Related]
17. Cellular host responses to gliomas.
Najbauer J; Huszthy PC; Barish ME; Garcia E; Metz MZ; Myers SM; Gutova M; Frank RT; Miletic H; Kendall SE; Glackin CA; Bjerkvig R; Aboody KS
PLoS One; 2012; 7(4):e35150. PubMed ID: 22539956
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma.
Duntsch C; Zhou Q; Weimar JD; Frankel B; Robertson JH; Pourmotabbed T
J Neurooncol; 2005 Feb; 71(3):245-55. PubMed ID: 15735912
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of JAM-A in gliomas.
Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
[TBL] [Abstract][Full Text] [Related]
20. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
